IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (Tregs) facilitate primary and metastatic tumour growth through the suppression of anti-tumour immunity. Emerging evidence suggests a distinct role for Tregs in mediating tissue repair and barrier integrity in the lungs by IL-33 mediated production of the growth factor amphiregulin (AREG). Dependent on the type of cancer and local microenvironment, AREG may induce tumour cell proliferation, invasion, migration or resistance to apoptosis by signaling through the epidermal growth factor receptor (EGFR). We have found that IL-33 is dramatically increased in and around metastatic tumour foci in the lungs of mice bearing orthotopic murine mammary tumours. We observed that Tregs express significantly more of the IL-33 receptor, ST2, relative to conventional T cells, that ST2+ Tregs accumulate in the lungs of metastatic tumour-bearing mice, and that ST2+ Tregs produce significantly more AREG than ST2− Tregs. The intranasal administration of recombinant IL-33 increased the proportion of AREG producing ST2+ Tregs and enhanced the level of phosphorylated EGFR in the metastatic lungs. While recombinant AREG did not impact mammary tumour cell proliferation in vitro despite inducing a dose-dependent increase in phosphorylated EGFR, intranasal administration of AREG resulted in a ten-fold increase in pulmonary metastatic tumour burden in vivo. Further, the intranasal administration of recombinant IL-33 significantly increased metastatic tumour burden in the lungs in an amphiregulin-dependent manner. These data identify ST2+ Tregs as a microenvironmental source of AREG in the lungs of mice with orthotopic metastatic mammary tumours and highlight an important role for AREG in promoting metastatic tumour growth in the lungs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2017) · Cell Research · doi:10.1038/cr.2016.151 · Cited by 1,860 · cited 1×
“As such, the systemic inhibition of Tregs, or targeting of their intra-tumoural homing or suppressive function, has become an active area of investigation.(36) In addition to immune suppression, Tregs may also facilitate tumour progression through the production of RANKL to suppress the EMT inhibitor maspin,(7) or by…”
BackgroundTumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376 · cited 2×
“In addition to immune suppression, Tregs may also facilitate tumour progression through the production of RANKL to suppress the EMT inhibitor maspin,(7) or by secretion of pro-angiogenic VEGFA.(37) Emerging literature indicates Tregs also promote tissue repair in the lungs by producing the growth factor AREG in respon…”
BackgroundInnate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179 · cited 1×
“lial and endothelial cells, as well as activated innate immune cells.(38) Under homeostatic conditions, IL-33 localizes to the nucleus and is exported to the cytoplasm for subsequent”
BackgroundA Distinct Function of Regulatory T Cells in Tissue Protection
Arpaia, N., Green, J. A., Moltedo, B., Arvey, A., Hemmers, S., Yuan, S., Treuting, P. M., & Rudensky, A. Y. (2015) · Cell · doi:10.1016/j.cell.2015.08.021 · Cited by 991
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677 · cited 1×
“To propagate the inflammatory response and facilitate tissue repair, innate immune cells may produce IL-33 to drive Th2 immunity.(40) We have found increased IL-33 in the”
BackgroundPoliti, K., Zakowski, M. F., Fan, P.-D., Schonfeld, E. A., Pao, W., & Varmus, H. E. (2006) · Genes & Development · doi:10.1101/gad.1417406 · Cited by 478 · cited 1×
“Positive control lung tissue for phospho-EGFR staining (Supplemental Figure 3) was obtained from CCSP-rtTA;TetO-EGFR transgenic mice with doxycycline-inducible expression of the activated EGFR mutant in type II airway epithelial cells.(34) Taken”
Method
Cited by
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046
Speiser, D. E., Chijioke, O., Schaeuble, K., & Münz, C. (2023) · Nature Cancer · doi:10.1038/s43018-023-00521-2 · Cited by 479
The Multifaceted Role of Regulatory T Cells in Breast Cancer
Kos, K., & de Visser, K. E. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042920-104912 · Cited by 58
“For example, IL-33 and CCL17 have both been reported to be released in metastatic foci in the lungs of 4T1 tumor–bearing mice, leading to the accumulation of Tregs that express the receptor for these molecules, thereby promoting metastasis (Halvorsen et al. 2019, Olkhanud et al. 2009).”
BackgroundLearning from the nexus of autoimmunity and cancer
Mangani, D., Yang, D., & Anderson, A. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.022 · Cited by 33
Metadata
- Authors
- Halvorsen, E. C., Franks, S. E., Wadsworth, B. J., Harbourne, B. T., Cederberg, R. A., Steer, C. A., Martinez-Gonzalez, I., Calder, J., Lockwood, W. W., & Bennewith, K. L.
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2018-10-16
- Volume
- 8
- Issue
- 2
- Pages
- e1527497
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- OpenAlex
- W2897635618
- Cited by
- 49
- References
- 8
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner. https://app.cochat.ai/papers/10.1080/2162402x.2018.1527497
- The paper
- Halvorsen, E. C., Franks, S. E., Wadsworth, B. J., Harbourne, B. T., Cederberg, R. A., Steer, C. A., Martinez-Gonzalez, I., Calder, J., Lockwood, W. W., & Bennewith, K. L. (2019). IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner. OncoImmunology. https://doi.org/10.1080/2162402x.2018.1527497
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.